1,115.70 USD
↘ 7.30 (0.65%)AT CLOSE (11:59 AM EDT)
Eli Lilly & Co.
LLYNYSE • USD
1,116.14
↗ 0.44 (0.04%)
POST MARKET (AS OF 08:14 PM EDT)
Post Market
AS OF 08:14 PM EDT
1,116.14
↗ 0.44 (0.04%)
Market: CLOSED
Shares of Eli Lilly & Co. (LLY) are trading at $1,115.70. LLY shows a split signal: underlying fundamentals suggest "Buy" while technical indicators indicate "Strong Sell". This is driven by a robust Altman Z-Score, exceptional Return on Equity (78.8%) and a bullish Golden Cross on the moving averages. On the valuation front, LLY trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Sep 11, 2026.
Open?$1,129.41
High?$1,131.44
Low?$1,113.29
Prev. Close?$1,123.00
Volume?1.8M
Avg. Volume?2.7M
VWAP?$1,119.37
Rel. Volume?0.68x
Bid / Ask
Bid?$1,116.00 × 40
Ask?$1,116.29 × 40
Spread?$0.29
Midpoint?$1,116.15
Valuation & Ratios
Market Cap?994.5B
Shares Out?941.4M
Float?849.7M
Float %?90.3%
P/E Ratio?37.23
P/B Ratio?29.35
EPS?$29.97
Dividend?0.58%
Ex-Dividend?N/A
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
994.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?100
Momentum?60
Short Sent.?54
Piotroski F-Score?6/9Mixed
Altman Z-Score?7.30Safe
Confidence?71%Moderate
Short InterestLow
Short % of Float?0.93%Low
Short Interest?7.9M
Days to Cover?3.0
Free Float849.7M
Avg Daily Volume2.6M
Settlement Date2026-08-31
Financial Health
Current Ratio?1.35Adequate
Quick Ratio?1.00Adequate
Cash Ratio?0.19Low
Debt/Equity?1.62High
ValuationRICHLY VALUEDvs 10 peers + S&P 500
Score33/100
P/E?37.2PRICEY▾
Peers40
S&P19
P/B?29.35HIGH▾
Peers10
S&P3
P/S?12.48HIGH▾
Peers20
S&P3
P/FCF?54.7PRICEY▾
Peers10
S&P9
EV/EBITDA?25.0HIGH▾
Peers30
S&P16
EV/Sales?13.06HIGH▾
Peers20
S&P6
Returns & Efficiency
ROE?78.8%STRONG▾
Peers89
S&P97
ROA?18.8%STRONG▾
Peers80
S&P93
Cash Flow & Enterprise
FCF?$18.2B
Enterprise Value?$1040.4B
Fundamentals ratios updated end of day